-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Pharmaceutical (688046.SH) announced that based on the company's overall development strategy and business needs, the company signed an “Share Acquisition Agreement” with the counterparty on November 16, 2026 to acquire 80% of the shares of Nanjing Baimai Biotechnology Co., Ltd. held by Jiang Yuwei, Henghui Pharmaceutical Group Co., Ltd. and Harbin Yuheng Pharmaceutical Co., Ltd. with its own capital and bank loans of 312 million yuan. After the transaction is completed, the company will hold 80% of Baimai Biotech's shares. Baimai Biotech will become the company's holding subsidiary and will be included in the company's consolidated statements.
Share
Listen to the news
Zhitong Finance App News, Pharmaceutical (688046.SH) announced that based on the company's overall development strategy and business needs, the company signed an “Share Acquisition Agreement” with the counterparty on November 16, 2026 to acquire 80% of the shares of Nanjing Baimai Biotechnology Co., Ltd. held by Jiang Yuwei, Henghui Pharmaceutical Group Co., Ltd. and Harbin Yuheng Pharmaceutical Co., Ltd. with its own capital and bank loans of 312 million yuan. After the transaction is completed, the company will hold 80% of Baimai Biotech's shares. Baimai Biotech will become the company's holding subsidiary and will be included in the company's consolidated statements.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending